Impact Factor
3.00
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.23
303 total citations
h5-index
12
h5 depth signal
Cited share
74.3%
104 of 140
Total citations
303
Citation footprint
Metric signal
1.88
External metric anchor
Self-citation
8.3%
25 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
342
Canada
18
Australia
10
United Kingdom
8
Brazil
6
Citing Fields of Research
Substance Abuse
360
Anesthetic & Pain Medicine
91
Psychiatry & Psychology
22
Psychiatry
19
Health Education & Remote Healthcare
19
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
394
Articles tracked across the journal lifetime
Indexed publication set
140
104 cited publications
Last 12 months
165
13.8 publications/month
Open access share
24.2%
40 OA publications in the last year
Leading citing country
United States
342 citing publications
Leading citing field
Substance Abuse
360 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v45n1, Jan. 2024-
v45n1, Jan. 2024-
Research Focus & Classification
Indexed Subjects
Substance Abuse
Issuing & Sponsoring Bodies
issuing body
Association for Multidisciplinary Education and Research in Substance use and Addiction
Broad Categories
Substance-Related Disorders
Substance Abuse
MeSH Descriptors
Behavior, Addictive
Substance-Related Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/29767342261493888
Open DOI
Takotsubo Cardiomyopathy Associated With Severe Medetomidine Withdrawal: A Case Report
Background: Takotsubo cardiomyopathy (TCM) is a transient syndrome of cardiac dysfunction with no occlusive coronary arterial disease, which may mimic an ischemic cardiac event. The pathogenesis of TCM is thought to be primarily driven b...
02
DOI 10.1177/29767342261489476
Open DOI
Impact of Opt-Out Versus Opt-In Recruitment on Engagement of FDNY WTC-Exposed Responders in a Tobacco Cessation Intervention
Background: World Trade Center (WTC)-exposed Fire Department of the City of New York (FDNY) rescue/recovery workers have an elevated risk of smoking-related morbidity. Despite access to free tobacco cessation treatment, some individuals ...
03
DOI 10.1177/29767342261489469
Open DOI
Centering Patient Health Over Legal Status: A Student-Driven Cannabis Risk Stratification Framework for Undergraduate Medical Education
Background: Cannabis use is increasing worldwide, both for evidence-supported indications and conditions with limited evidence such as anxiety, depression, and chronic pain. Although incongruence between state and federal cannabis laws h...
04
DOI 10.1177/29767342261492538
Open DOI
Characterizing Buprenorphine Dosing Frequency During Outpatient Medication Treatment For Opioid Use Disorder
Background: Sublingual buprenorphine for opioid use disorder (OUD) is indicated as a once-daily medication during stabilization and long-term treatment, yet patients may engage in “split dosing,” dividing the daily dose into multiple adm...
05
DOI 10.1177/29767342261479908
Open DOI
State Variation in the Availability of Women-Specific Alcohol Use Disorder Treatment
Background: In the United States (U.S.), the prevalence of alcohol use disorder (AUD) is increasing among women; however, few women seek treatment. System-level information on the need for AUD treatment among women and the availability o...
06
DOI 10.1177/29767342261489466
Open DOI
Association of Cannabis Use With Cigarette Use in People Certified for Medical Cannabis for Chronic Pain: A Secondary Analysis of a Prospective Cohort Study
Background: Chronic pain is associated with cigarette use and cannabis use and people with chronic pain report using each to manage pain. Little is known about how medical cannabis legalization impacts cigarette use among people with chr...
07
DOI 10.1177/29767342261489216
Open DOI
“You Do What You Have To Do”: Risk Environments in Xylazine Wound Care
Background: Xylazine, a veterinary sedative, has become a prevalent adulterant in the unregulated opioid supply and can lead to chronic ulcerative wounds among people who use drugs (PWUD). Without regular care, these wounds can progress ...
08
DOI 10.1177/29767342261490083
Open DOI
Acceptability, Appropriateness, and Feasibility of Implementing the Locus-of-Hope Enhancement Program: Perspectives of Substance Use Disorder Treatment Providers
Background: Positive psychological interventions have been introduced in substance use disorder (SUD) treatment, yet the possibility of multisite implementation of programs that cater to hope as a positive cognitive disposition based on ...
09
DOI 10.1177/29767342261489718
Open DOI
Perspectives of Racial and Ethnic Emergency Department Patient–Clinician Concordance in Opioid Use Disorder Encounters
Background: Significant racial and ethnic disparities in the treatment of opioid use disorder (OUD) in the emergency department (ED) remain. Little is known about how ED patients with OUD perceive racial and ethnic concordance and whethe...
10
DOI 10.1177/29767342261489719
Open DOI
“I Just Knew That I Needed Help”: Primarily Latine Adolescents and Young Adults Speak About Medication Treatment for Opioid Use Disorder in the Fentanyl Era
Background: Medications for opioid use disorder (MOUD) are evidence-based, lifesaving treatments for adolescents and young adults (AYAs) with opioid use disorder (OUD). However, AYAs access MOUD at alarmingly low rates. Therefore, this s...